BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, February 8, 2026
Home » Authors » Mark McCarty

Mark McCarty

Articles

ARTICLES

Washington roundup: Mainline leaves diagnostics business after warning letter

June 11, 2009
By Mark McCarty

Washington roundup: Family business owner: FDA audits 'rudimentary' in 60s

June 10, 2009
By Mark McCarty

Washington roundup: NIH to license aortic valve stent, other technologies

June 9, 2009
By Mark McCarty

Washington roundup: Mainline leaves diagnostics business after warning letter

June 8, 2009
By Mark McCarty

Clinical sites see money as issue when looking at PAS

June 8, 2009
By Mark McCarty
SILVER SPRING, Maryland – The post-approval study (PAS) is one of the most frustrating parts of the development process for makers of novel devices, not just because patients are not particularly eager to enroll. (Medical Device Daily)
Read More

Comparative effectiveness not seen bending cost curve

June 5, 2009
By Mark McCarty

Scrutiny of device industry unlikely to ebb anytime soon

June 5, 2009
By Mark McCarty
WASHINGTON — The second day of this year's annual meeting of the Medical Device Manufacturers Association (MDMA; Washington) covered a couple of hot-button topics, and a session that got the audience's rapt attention was one that dealt with compliance issues in an era of increasing governmental scrutiny. (Medical Device Daily)
Read More

Schultz: de novo 510(k) path not used to 'maximum effect'

June 4, 2009
By Mark McCarty
WASHINGTON – Dan Schultz, MD, director of the Center for Devices and Radiological Health at FDA, gave a brief address at this year's annual meeting of the Medical Device Manufacturers Association (MDMA; Washington), and had a lot to say about a lot of things. (Medical Device Daily)
Read More

HIT: Healthcare InfoTech Business Report – Washington roundup: HIT plan lacks deadline to define term 'meaningful user'

June 3, 2009
By Mark McCarty

Venture capital pullback puts more pressure on start-ups

June 3, 2009
By Mark McCarty
WASHINGTON – Funding for med-tech start-ups already was thought to be a looming issue last year as the economy faltered, and this year's annual meeting of the Medical Device Manufacturers Association (MDMA; Washington), which opened here Tuesday, made clear that the worry is not strictly an expression of paranoia. (Medical Device Daily)
Read More
View All Articles by Mark McCarty

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Feb. 6, 2025.
  • Brain illustration

    MJFF grant supports Bexorg’s translational biomarker work

    BioWorld Science
    Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
  • Brain and DNA

    REST emerges as biomarker in ALS, knockdown improves ALS symptoms

    BioWorld Science
    About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
  • Brain illustrated with pills

    Serotonin receptor modulators for the treatment of OUD

    BioWorld Science
    Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
  • Liver anatomy illustration

    KLF15 shows potential as marker, target for cholangiocarcinoma

    BioWorld Science
    Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing